Suchergebnisse - "Senhaji, Nezha"

PubPharm (30)

21

Genetic Polymorphisms of Multidrug Resistance Gene-1 (MDR1/ABCB1) and Glutathione S-Transferase Gene and the Risk of Inflammatory Bowel Disease among Moroccan Patients

enthalten in: Mediators of inflammation | 2015

von Senhaji, N. | Kassogue, Y. | Fahimi, M. | +3

22

Genetic Polymorphisms of Multidrug Resistance Gene-1 (MDR1/ABCB1) and Glutathione S-Transferase Gene and the Risk of Inflammatory Bowel Disease among Moroccan Patients

enthalten in: Mediators of inflammation | 2015

von Senhaji, N. | Kassogue, Y. | Fahimi, M. | +3

23

Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms : New data and a meta-analysis

enthalten in: BMC gastroenterology | 2014

von Senhaji, N. | Diakité, B. | Serbati, N. | +3

24

Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms: New data and a meta-analysis

enthalten in: BMC gastroenterology | 2014

von Senhaji, N. | Diakité, B. | Serbati, N. | +3

25

Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms: New data and a meta-analysis

enthalten in: BMC gastroenterology | 2014

von Senhaji, N. | Diakité, B. | Serbati, N. | +3

26

IL23R and ATG16L1 variants in Moroccan patients with inflammatory bowel disease

enthalten in: BMC research notes | 2014

von Serbati, N. | Senhaji, N. | Diakite, B. | +2

27

IL23R and ATG16L1 variants in Moroccan patients with inflammatory bowel disease

enthalten in: BMC Research Notes | 2014

von Serbati, N. | Senhaji, N. | Diakite, B. | +2

28

IL23R and ATG16L1 variants in Moroccan patients with inflammatory bowel disease

enthalten in: BMC Research Notes | 2014

von Serbati, N. | Senhaji, N. | Diakite, B. | +2

29

Methylenetetrahydrofolate reductase C677T variant in Moroccan patients with inflammatory bowel disease

enthalten in: Gene | 2013

von Senhaji, N. | Serbati, N. | Diakité, B. | +4

30

Methylenetetrahydrofolate reductase C677T variant in Moroccan patients with inflammatory bowel disease

enthalten in: Gene | 2013

von Senhaji, N. | Serbati, N. | Diakité, B. | +4